AGAH Conference 2026

Richmond Pharmacology is excited to join the AGAH Conference 2026 in Frankfurt, Germany, on 25- 26 February 2026.

Bringing together experts in clinical pharmacology and early-phase drug development, this conference is a key platform for advancing methodologies, regulatory strategies, and innovation in human pharmacology.

Representing Richmond Pharmacology:

• Dr Jörg Taubel, Chief Executive Officer and President at AGAH ‍
• Dr Lisa Campbell, Director of Regulatory Strategy‍
• James Rickard, Chief Scientific Officer (Richmond Research Institute)
• Elizabeth Romano, Director of Communications and Participant Engagement

‍

We look forward to connecting with attendees to discuss Richmond’s expertise in:

• Innovations in early-phase trial design and execution

• Regulatory frameworks for first-in-human studies

• Biomarker-driven approaches to accelerate development

• Patient-centric strategies in early-phase research

• Collaboration between academia, industry, and regulators

Connect With Us

If you are attending AGAH Conference 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

‍